131 related articles for article (PubMed ID: 33391349)
1. A Pan-Cancer Study of Epidermal Growth Factor-Like Domains 6/7/8 as Therapeutic Targets in Cancer.
Shi S; Ma T; Xi Y
Front Genet; 2020; 11():598743. PubMed ID: 33391349
[TBL] [Abstract][Full Text] [Related]
2. Molecular characterization and expression analysis of mouse epidermal growth factor-like domain 8.
Song IJ; Ikram M; Subhan F; Choi DJ; Lee JR; Kim HS; Lim YT; Yoon S
Int J Mol Med; 2015 Aug; 36(2):541-50. PubMed ID: 26096343
[TBL] [Abstract][Full Text] [Related]
3. A pan-cancer study of class-3 semaphorins as therapeutic targets in cancer.
Zhang X; Klamer B; Li J; Fernandez S; Li L
BMC Med Genomics; 2020 Apr; 13(Suppl 5):45. PubMed ID: 32241267
[TBL] [Abstract][Full Text] [Related]
4. A Pan-Cancer Analysis of the BIRC Gene Family and Its Association with Prognosis, Tumor Microenvironment, and Therapeutic Targets.
Wu S; Zang Q; Xing Z; Li X; Leng J; Liu Y; Wang X; Yang J
Crit Rev Eukaryot Gene Expr; 2021; 31(4):35-48. PubMed ID: 34587434
[TBL] [Abstract][Full Text] [Related]
5. Progress of EGFL6 in angiogenesis and tumor development.
Su G; Wang W; Xu L; Li G
Int J Clin Exp Pathol; 2022; 15(11):436-443. PubMed ID: 36507067
[TBL] [Abstract][Full Text] [Related]
6. EGFL6 promotes breast cancer by simultaneously enhancing cancer cell metastasis and stimulating tumor angiogenesis.
An J; Du Y; Fan X; Wang Y; Ivan C; Zhang XG; Sood AK; An Z; Zhang N
Oncogene; 2019 Mar; 38(12):2123-2134. PubMed ID: 30455428
[TBL] [Abstract][Full Text] [Related]
7. The emerging role of EGFL6 in angiogenesis and tumor progression.
Kang J; Wang J; Tian J; Shi R; Jia H; Wang Y
Int J Med Sci; 2020; 17(10):1320-1326. PubMed ID: 32624687
[TBL] [Abstract][Full Text] [Related]
8. A pan-cancer study of spalt-like transcription factors 1/2/3/4 as therapeutic targets.
Ma T; Shi S; Jiang H; Chen X; Xu D; Ding X; Zhang H; Xi Y
Arch Biochem Biophys; 2021 Oct; 711():109016. PubMed ID: 34411579
[TBL] [Abstract][Full Text] [Related]
9. Validation of EGFL6 expression as a prognostic marker in patients with lung adenocarcinoma in Taiwan: a retrospective study.
Chang CC; Sung WW; Hsu HT; Yeh CM; Lee CH; Chen YL; Liu TC; Yeh KT
BMJ Open; 2018 Jun; 8(6):e021385. PubMed ID: 29934389
[TBL] [Abstract][Full Text] [Related]
10. A pan-cancer analysis of the HER family gene and their association with prognosis, tumor microenvironment, and therapeutic targets.
Yang X; Miao Y; Wang J; Mi D
Life Sci; 2021 May; 273():119307. PubMed ID: 33691171
[TBL] [Abstract][Full Text] [Related]
11. Effect of myeloid ecotropic viral integration site (MEIS) family genes on tumor microenvironment remodeling and its potential therapeutic effect.
Meng L; Tian Z; Wang J; Liu X; Zhang W; Hu M; Wang M; Zhang Y
Transl Androl Urol; 2021 Feb; 10(2):594-608. PubMed ID: 33718062
[TBL] [Abstract][Full Text] [Related]
12. A comprehensive analysis and validation of cuproptosis-associated genes across cancers: Overall survival, the tumor microenvironment, stemness scores, and drug sensitivity.
Liu J; Lu Y; Dai Y; Shen Y; Zeng C; Liu X; Yu H; Deng J; Lu W
Front Genet; 2022; 13():939956. PubMed ID: 36105090
[No Abstract] [Full Text] [Related]
13. Knockout of
Zhu W; Liu C; Lu T; Zhang Y; Zhang S; Chen Q; Deng N
Front Oncol; 2020; 10():1451. PubMed ID: 32983976
[TBL] [Abstract][Full Text] [Related]
14. A Pan-Cancer Study of KMT2 Family as Therapeutic Targets in Cancer.
Zhu J; Liu Z; Liang X; Wang L; Wu D; Mao W; Shen D
J Oncol; 2022; 2022():3982226. PubMed ID: 35058979
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value and immune characteristics of RUNX gene family in human cancers: a pan-cancer analysis.
Zhao H; Chen Y; Shen P; Gong L
Aging (Albany NY); 2022 May; 14(9):4014-4035. PubMed ID: 35522574
[TBL] [Abstract][Full Text] [Related]
16. Pan‑cancer analysis of the deoxyribonuclease gene family.
Bai Q; He X; Hu T
Mol Clin Oncol; 2023 Mar; 18(3):19. PubMed ID: 36798465
[TBL] [Abstract][Full Text] [Related]
17. EGFL7: Master regulator of cancer pathogenesis, angiogenesis and an emerging mediator of bone homeostasis.
Hong G; Kuek V; Shi J; Zhou L; Han X; He W; Tickner J; Qiu H; Wei Q; Xu J
J Cell Physiol; 2018 Nov; 233(11):8526-8537. PubMed ID: 29923200
[TBL] [Abstract][Full Text] [Related]
18. EGFL7 is expressed in bone microenvironment and promotes angiogenesis via ERK, STAT3, and integrin signaling cascades.
Chim SM; Kuek V; Chow ST; Lim BS; Tickner J; Zhao J; Chung R; Su YW; Zhang G; Erber W; Xian CJ; Rosen V; Xu J
J Cell Physiol; 2015 Jan; 230(1):82-94. PubMed ID: 24909139
[TBL] [Abstract][Full Text] [Related]
19. High Level of Plasma EGFL6 Is Associated with Clinicopathological Characteristics in Patients with Oral Squamous Cell Carcinoma.
Chuang CY; Chen MK; Hsieh MJ; Yeh CM; Lin CW; Yang WE; Yang SF; Chou YE
Int J Med Sci; 2017; 14(5):419-424. PubMed ID: 28539817
[TBL] [Abstract][Full Text] [Related]
20. EGFL6 promotes cell proliferation in colorectal cancer via regulation of the WNT/β-catenin pathway.
Zhang QW; Zhang XT; Tang CT; Lin XL; Ge ZZ; Li XB
Mol Carcinog; 2019 Jun; 58(6):967-979. PubMed ID: 30693973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
